A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population

Clinical Transplantation

Volumn 24, Issue 3, 2010, Pages

  Davis, C S ^a   Gagermeier, J ^a   Dilling, D ^a   Alex, C ^a   Lowery, E ^a   Kovacs, E J ^a   Love, R B ^a   Fisichella, P M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aspiration; Bronchiolitis obliterans syndrome; Chronic allograft dysfunction; Exhaled breath condensate; Gastroesophageal reflux; Lung transplantation

Indexed keywords

BIOLOGICAL MARKER;

ASSAY; BRONCHIOLITIS OBLITERANS; EXHALED BREATH CONDENSATE; GASTROESOPHAGEAL REFLUX; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LUNG ASPIRATION; LUNG FUNCTION; LUNG LAVAGE; LUNG TRANSPLANTATION; NON INVASIVE MEASUREMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING; TECHNIQUE; ACID ASPIRATION; BREATHING DISORDER; CHEMISTRY;

BIOLOGICAL MARKERS; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; GASTROESOPHAGEAL REFLUX; HUMANS; LUNG TRANSPLANTATION; RESPIRATION DISORDERS; RESPIRATORY ASPIRATION;

EID: 77954169734     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01243.x     Document Type: Review

References (74)

1. Wilkes DS, Egan TM, Reynolds HY. Lung transplantation: opportunities for research and clinical advancement. Am J Respir Crit Care Med 2005, 172:944.
2. Christie JD, Edwards LB, Aurora P. Registry for the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report. J Heart Lung Transplant 2008, 27:957.
3. Garrity ER, Moore J, Mulligan MS, Shearon TH, Zucker MJ, Murray S. Heart and lung transplantation in the United States, 1996-2005. Am J Transplant 2007, 7(5 Pt 2):1390.
4. Brown RS, Rush SH, Rosen HR. Liver and intestine transplantation. Am J Transplant 2004, 4(Suppl. 9):81.
5. Wynn JJ, Distant DA, Pirsch JD. Kidney and pancreas transplantation. Am J Transplant 2004, 4(Suppl. 9):72.
6. Pierson RN, Barr ML, McCullough KP. Thoracic organ transplantation. Am J Transplant 2004, 4(Suppl. 9):93.
7. Orens JB, Garrity ER. General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc 2009, 6:13.
8. Yousem SA, Berry GJ, Cagle PT. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996, 15(1 Pt 1):1.
9. Grossman EJ, Shilling RA. Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Transl Res 2009, 153:153.
10. Cooper JD, Billingham M, Egan T. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993, 12:713.
11. Estenne M, Maurer JR, Boehler A. Bronchiolitis obliterans syndrome 2001, an update of the diagnostic criteria. J Heart Lung Transplant 2002, 21:297.
12. Valentine VG, Robbins RC, Berry GJ. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996, 15:371.
13. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002, 166:440.
14. Nicod LP. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 2006, 3:444.
15. Belcher JR. The pulmonary complications of dysphagia. Thorax 1949, 4:44.
16. Davis MV. Evolving concepts regarding hiatal hernia and gastroesophageal reflux. Ann Thorac Surg 1969, 7:120.
17. Pearson JE, Wilson RS. Diffuse pulmonary fibrosis and hiatus hernia. Thorax 1971, 26:300.
18. Mays EE, Dubois JJ, Hamilton GB. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976, 69:512.
19. Tobin RW, Pope CE, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 158:1804.
20. Hadjiliadis D, Davis RD, Steele MP. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003, 17:363.
21. D'Ovidio F, Mura M, Ridsdale R. The effect of reflux and bile acid aspiration on lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 2006, 6:1930.
22. Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest 2003, 124:1689.
23. D'Ovidio F, Keshavjee S. Gastroesophageal reflux and lung transplantation. Dis Esophagus 2006, 19:315.
24. D'Ovidio F, Mura M, Tsang M. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. Thorac Cardiovasc Surg 2005, 129:1144.
25. D'Ovidio F, Mura M, Waddell TK. Bile acids in bronchoalveolar lavage after lung transplantation as a marker of pulmonary aspiration associated with alveolar neutrophilia. J Heart Lung Transplant 2005, 23(2 Suppl. 1):42S.
26. Reid KR, McKenzie FN, Menkis AH. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet 1990, 336:206.
27. Abernathy EC, Hruben RH, Baumgartner WA, Reitz BA, Hutchins GM. The two forms of bronchiolitis obliterans in heart-lung transplant recipients. Hum Pathol 1991, 22:1102.
28. Hartwig MG, Appel JZ, Li B. Chronic aspiration of gastric fluid accelerates pulmonary allograft dysfunction in a rat model of lung transplantation. J Thorac Cardiovasc Surg 2006, 131:209.
29. Li B, Hartwig MG, Appel JZ. Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant 2008, 8:1614.
30. Sweet MP, Patti MG, Hoopes C, Hays SR, Golden JA. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax 2009, 64:167.
31. Sweet MP, Herbella FA, Leard L. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg 2006, 244:491.
32. Farrell S, McMaster C, Gibson D, Shields MD, McCallion WA. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration. J Pediatr Surg 2006, 41:289.
33. Au J, Hawkins T, Venables C. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg 1993, 55:94.
34. Bodet-Milin C, Querellou S, Oudoux A. Delayed gastric emptying scintigraphy in cystic fibrosis patients before and after lung transplantation. J Heart Lung Transplant 2006, 25:1077. Epub 2006 Jul 10
35. Berkowitz N, Schulman LL, McGregor C, Markowitz D. Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications. Chest 1995, 108:1602.
36. Tamhankar AP, Peters JH, Portale G. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 2004, 8:890. discussion 897-8
37. Blondeau K, Mertens V, Vanaudenaerde BA. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2008, 31:707.
38. Hartwig MG, Appel JZ, Davis RD. Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. Thorac Surg Clin 2005, 15:417.
39. Lau CL, Palmer SM, Howell DN. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 2002, 16:1674.
40. Gasper WJ, Sweet MP, Hoopes C. Antireflux surgery for patients with end-stage lung disease before and after lung transplantation. Surg Endosc 2008, 22:495.
41. Linden PA, Gilbert RJ, Yeap BY. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 2006, 131:438.
42. O'Halloran EK, Reynolds JD, Lau CL. Laparoscopic Nissen fundoplication for treating reflux in lung transplant recipients. J Gastrointest Surg 2004, 8:132.
43. Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000, 118:1214.
44. Davis RD, Lau CL, Eubanks S. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003, 125:533.
45. Cantu E, Appel JZ, Hartwig MG. J Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004, 78:1142.
46. D'Ovidio F, Singer LG, Hadjiliadis D. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg 2005, 80:1254.
47. Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliott MJ. High prevalence of gastroesophageal reflux disease in lung transplant recipients. Pediatr Pulmonol 2005, 40:68.
48. Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 1993, 104:1511.
49. Oelschlager BK, Chang L, Pope CE, Pellegrini CA. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux. J Surg Res 2005, 128:55.
50. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991, 101(4 Pt 2 Suppl. 53):1.
51. Oelschlager BK, Pellegrini CA. Minimally invasive surgery for gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A 2001, 11:341.
52. Oelschlager BK, Eubanks TR, Oleynikov D, Pope C, Pellegrini CA. Symptomatic and physiologic outcomes after operative treatment for extraesophageal reflux. Surg Endosc 2002, 16:1032.
53. Pellegrini CA, DeMeester TR, Johnson LF, Skinner DB. Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy. Surgery 1979, 86:110.
54. Eubanks TR, Omelanczuk P, Hillel A, Maronian N, Pope CE, Pellegrini CA. Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy. Am J Surg 2001, 181:466.
55. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol 1997, 92:825.
56. Bredenoord AJ, Tutuian R, Smout AJ, Castell DO. Technology review: esophageal impedance monitoring. Am J Gastroenterol 2007, 102:187.
57. Dransfield MT, Garver RI, Weill D. Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipients. J Heart Lung Transplant 2004, 23:110.
58. Valentine VG, Taylor DE, Dhillon GS. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002, 21:319.
59. Tiroke AH, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant 1999, 13:131.
60. McWilliams TJ, Williams TJ, Whitford HM, Snell GI. Surveillance bronchoscopy in lung transplant recipients: risk versus benefit. J Heart Lung Transplant 2008, 27:1203.
61. Ward C, Forrest IA, Brownlee IA. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 2005, 60:872.
62. Stovold R, Forrest IA, Corris PA. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med 2007, 175:1298.
63. Sidorenko GI, ZborovskiǏ EI, Levina DI. Surface-active properties of the exhaled air condensate (a new method of studying lung function. Ter Arkh 1980, 52:65.
64. Hunt J. Exhaled breath condensate: an overview. Immunol Allergy Clin North Am 2007, 27:587.
65. Walsh BK, Mackey DJ, Pajewski T, Yu Y, Gaston BM, Hunt JF. Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients. Respir Care 2006, 51:1125.
66. Muller WG, Morini F, Eaton S, Peters M, Jaffe A. Safety and feasibility of exhaled breath condensate collection in ventilated infants and children. Eur Respir J 2006, 28:479.
67. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002, 110:28.
68. Horváth I, Hunt J, Barnes PJ. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005, 26:523.
69. Ono E, Mita H, Taniguchi M. Comparison of cysteinyl leukotriene concentrations between exhaled breath condensate and bronchoalveolar lavage fluid. Clin Exp Allergy 2008, 38:1866.
70. Jackson AS, Sandrini A, Campbell C, Chow S, Thomas PS, Yates DH. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 2007, 175:222.
71. Dupont LJ, Dewandeleer Y, Vanaudenaerde BM, Van Raemdonck DE, Verleden GM. The pH of exhaled breath condensate of patients with allograft rejection after lung transplantation. Am J Transplant 2006, 6:1486.
72. Hunt J, Yu Y, Burns J. Identification of acid reflux cough using serial assays of exhaled breath condensate pH. Cough 2006, 2:3.
73. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002, 10:1364.
74. Krishnan A, Chow S, Thomas P, Malouf M, Glanville A, Yates D. Exhaled breath condensate pepsin: a new noninvasive marker of GERD after lung transplantation. J Heart Lung Transplant 2007, 26(2 Suppl. 1):S139.